By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Prolong Pharmaceuticals 

7 Deer Park Drive
Suite F
Monmouth Junction  New Jersey  08852  U.S.A.
Phone: 732-438-1133 Fax: 732-438-1138



Company News
Prolong Pharmaceuticals Release: New Research Suggests SANGUINATE Reduces The Number Of Sickled Red Blood Cells In Patients With Vaso-Occlusive Crisis 5/2/2017 8:00:35 AM
Prolong Pharmaceuticals Presents Data On Unique "Un-Sickling" In Vitro Activity Observed In Sickle Cell Investigational Drug SANGUINATE 4/14/2015 11:17:49 AM
Prolong Pharmaceuticals' Flagship Product SANGUINATE Granted Orphan Drug Designation By The FDA 4/8/2015 10:25:57 AM
Prolong Pharmaceuticals Adds Industry Veteran Ronald Jubin To Executive Management Team 12/19/2013 6:13:58 AM
Prolong Pharmaceuticals Presents Phase 1 Results for Flagship Product SANGUINAT 10/3/2013 10:11:57 AM
Prolong Pharmaceuticals Presents Novel Multi-Pronged Approach to Treating Sickle Cell Disease at the SCDAA Meeting 9/27/2013 9:38:00 AM
Prolong Pharmaceuticals's Large Scale Manufacturing of Sickle Cell Product to be Headed by Industry Veteran 12/15/2011 11:16:45 AM
Dr. Abraham Abuchowski of Prolong Pharmaceuticals Honored With Inaugural Tibbetts Award by the U.S. Small Business Administration 2/17/2011 8:29:44 AM
Prolong Pharmaceuticals Boosts Executive Team 11/18/2010 9:03:03 AM
Prolong Pharmaceuticals Secures $30 Million in Funding 10/14/2010 8:08:26 AM